BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37555592)

  • 1. 'With this study, we have hope that something is coming': community members' perceptions of HIV cure-related research in Durban, South Africa - a qualitative focus group study.
    Dubé K; Mthimkhulu D; Ngcobo W; Mindry D; Maphalala L; Pillay V; Tran W; Korolkova A; Ndung'u T; Dong K
    HIV Res Clin Pract; 2023 Jul; 24(1):2243046. PubMed ID: 37555592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
    Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
    Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
    AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
    Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
    HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
    Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
    HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
    Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
    HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
    [No Abstract]   [Full Text] [Related]  

  • 10. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
    Dubé K; Kanazawa J; Roebuck C; Johnson S; Carter WB; Dee L; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
    HIV Res Clin Pract; 2022 Dec; 23(1):120-135. PubMed ID: 35348047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.
    Dubé K; Barr E; Philbin M; Perez-Brumer A; Minalga B; Peterson B; Averitt D; Picou B; Martel K; Chung C; Mejía M; Cameron M; Graham G; Dee L; Dixon Diallo D; Gordon E; Korolkova A; Dyer T; Auerbach JD; Scully E; Dong KL; Gianella S
    HIV Res Clin Pract; 2023 Aug; 24(1):2246717. PubMed ID: 37608645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring a community's understanding of HIV vaccine‑induced seropositivity in a South African research setting.
    Malahleha M; Dilraj A; Jean J; Morar NS; Dietrich JJ; Ross M; Mbatsane E; Keefer MC; Ahmed K
    S Afr Med J; 2022 Dec; 113(1):36-41. PubMed ID: 36537546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.
    Moodley K; Staunton C; de Roubaix M; Cotton M
    AIDS Care; 2016; 28(4):524-7. PubMed ID: 26565595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa.
    Moodley K; Rossouw T; Staunton C; Colvin CJ
    BMC Med Ethics; 2016 Apr; 17(1):26. PubMed ID: 27137204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
    Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
    J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge transmission, peer support, behaviour change and satisfaction in post Natal clubs in Khayelitsha, South Africa: a qualitative study.
    Duvivier H; Decroo T; Nelson A; Cassidy T; Mbakaz Z; Duran LT; de Azevedo V; Solomon S; Venables E
    Reprod Health; 2020 Jul; 17(1):107. PubMed ID: 32641072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I Would Absolutely Need to Know That My Partner Is Still Going to be Protected": Perceptions of HIV Cure-Related Research Among Diverse HIV Serodifferent Couples in the United States.
    Dubé K; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):400-413. PubMed ID: 35972752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life.
    Perry KE; Taylor J; Patel H; Javadi SS; Mathur K; Kaytes A; Concha-Garcia S; Little S; Smith D; Gianella S; Dubé K
    PLoS One; 2020; 15(11):e0242420. PubMed ID: 33206710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States.
    Sylla L; Patel H; Louella M; Simoni J; Dubé K
    HIV Res Clin Pract; 2022 Jul; 23(1):61-75. PubMed ID: 35904107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.